Filing Details
- Accession Number:
- 0001181431-14-007431
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-18 18:03:53
- Reporting Period:
- 2014-02-13
- Filing Date:
- 2014-02-18
- Accepted Time:
- 2014-02-18 18:03:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
879169 | Incyte Corp | INCY | Services-Commercial Physical & Biological Research (8731) | 943136539 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1329010 | Laurent Chardonnet | Experimental Station Route 141 &Amp; Henry Clay Road Wilmington DE 19880 | No | No | No | Yes |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-02-13 | 25,523 | $8.99 | 28,716 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2014-02-13 | 3,888 | $3.11 | 32,604 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2014-02-13 | 14,477 | $8.99 | 47,081 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2014-02-13 | 3,334 | $6.95 | 50,415 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2014-02-13 | 8,874 | $11.98 | 59,289 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2014-02-13 | 31,126 | $11.98 | 90,415 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2014-02-13 | 11,112 | $3.11 | 101,527 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-02-13 | 98,334 | $66.28 | 3,193 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-02-13 | 25,523 | $0.00 | 25,523 | $8.99 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-02-13 | 3,888 | $0.00 | 3,888 | $3.11 |
Common Stock | Incentive Stock Option (right to buy) | Disposition | 2014-02-13 | 14,477 | $0.00 | 14,477 | $8.99 |
Common Stock | Incentive Stock Option (right to buy) | Disposition | 2014-02-13 | 3,334 | $0.00 | 3,334 | $6.95 |
Common Stock | Incentive Stock Option (right to buy) | Disposition | 2014-02-13 | 8,874 | $0.00 | 8,874 | $11.98 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-02-13 | 31,126 | $0.00 | 31,126 | $11.98 |
Common Stock | Incentive Stock Option (right to buy) | Disposition | 2014-02-13 | 11,112 | $0.00 | 11,112 | $3.11 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2015-01-17 | No | 4 | M | Direct | |
0 | 2016-01-26 | No | 4 | M | Direct | |
0 | 2015-01-17 | No | 4 | M | Direct | |
0 | 2015-05-02 | No | 4 | M | Direct | |
0 | 2015-02-07 | No | 4 | M | Direct | |
0 | 2015-02-07 | No | 4 | M | Direct | |
0 | 2016-01-26 | No | 4 | M | Direct |
Footnotes
- Beginning January 18, 2005, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
- Beginning January 27, 2009, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
- Beginning May 2, 2005, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
- Beginning February 8, 2008, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
- Represents weighted average sale price. Actual sales prices ranged from $66.00-$67.46.
- Reporting person undertakes to provide upon request by Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.